B3 Labs CBD products achieve novel foods status

By Gwen Ridler contact

- Last updated on GMT

B3 Labs has achieved novel foods status for its CBD products
B3 Labs has achieved novel foods status for its CBD products

Related tags: Cbd, Cannabis, Novel food

B3 Labs is the latest UK-based cannabidiol (CBD) producer to achieve novel foods status.

The approval followed the publication of the CBD products linked to novel food applications last week, which saw more up 6,000 added to the list. The Food Standards Agency has recorded nearly 12,000 products on this list.

B3 labs has 525 products on the list, placing it within the top five manufacturers by stock keeping unit count.

Businesses can continue to apply for the authorisation of CBD food products through the regulated food process. However, new applications would not be eligible for the public list and should not be put on sale until they have been authorised.

‘Landmark moment’

Commenting on the approval, chief executive Marc Burbidge said: “This is a landmark moment for B3 Labs, but also Europe’s cannabis market as a whole. At B3 we are committed to ensuring consumers know what they are getting when purchasing CBD products, and today’s news is a major step in our growth journey.

“We hope to see more of the consumer cannabis market following suit to drive transparency and assurance across the industry.”

Burbidge’s comments followed a report published by cannabis research group Leafreport that claimed there was a lack of transparency and third-party testing in the consumer cannabis market.

Inaccurate labels

It also claimed that the majority of CBD consumer goods were not labelled with accurate information about their purity and potency.

B3 Labs produces a range of CBD oils, gummies and vapes and was recently acquired by UK based specialist cannabis distributor Sana Life Science. It operates in a number of markets across Europe, including the UK and Germany.

Meanwhile, last month, the UK Government was urged to stop taking a ‘disinterested, distanced and laissez faire’ attitude to the cannabis sector​,​ according to a new report from stakeholders in the industry.

The report proposed a regulatory framework that would achieve three important objectives: create global competitive advantage for the UK post Brexit; create regulatory best practice for future novel products; and reinforce the UK’s status as an innovator and world leader on issues of environment, health and quality of life. 

Related topics: Food Safety

Related news

Show more

comments

Post your comment

We will not publish your email address on the website

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Follow us

Products

View more

Webinars

PRODUCTS & SERVICES